News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Entheon Biomedical Corp. Announces DTC Eligibility
Entheon Biomedical
Tryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of Florida
Tryp Therapeutics
MindMed Announces Collaboration With Forian To Advance Development Of Personalized Psychiatry For Anxiety Disorders
Mind Medicine (MindMed)
Dr. Paul Van Slyke | Chief Scientific Officer, PharmaDrug
Pharmadrug Inc.
Ketamine One Establishes Medical Advisory Board
Wellbeing Digital Sciences
Mydecine Innovations Group signs five-year Master Collaboration Research Agreement with Johns Hopkins University School of Medicine
Mydecine Innovations Group
Clearmind Medicine Commences Trading on the Frankfurt Stock Exchange
Clearmind Medicine
Psyence Group Announces the Commencement of Online Sales and Distribution of “GOODMIND” Products
Psyence Group
Optimi Health Clears Final Base Shelf Prospectus
Optimi Health
Revive Therapeutics Signs Exclusive Worldwide License Agreement For Medicinal Mushroom Ganoderma Lucidum To Treat Cancer
Revive Therapeutics
Diamond Therapeutics Announces Health Canada Approval of Clinical Trial with Low-Dose Psilocybin
Diamond Therapeutics
Psyched Wellness Submits Applications for Four Further Provisional Patents Surrounding Its Work on the AME-1
Psyched Wellness
Braxia Scientific Announces Participation at H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021
Braxia Scientific Corp.
NeonMind Receives Health Canada Approval for its Functional Mushroom Formulation 'Mindful Blend'
NeonMind Biosciences Inc.
MindMed Joins Critical Path Institute's Patient-Reported Outcome Consortium
Mind Medicine (MindMed)
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.